Search…

FDA rejects muscle disease drug application, Capricor Therapeutics (CAPR.US) plummets in pre-market trading.

12/07/2025

Zhtng cijng APP huxn, yuy migu jingun jgu bjule gngs y kun zhm xng jru jbng zhlio yow de shnqng, Capricor Therapeutics(CAPR.US) gji yd bo di y 60%. According to the Zhitong Finance APP, due to the rejection of a deadly muscle disease treatment drug application by US regulatory agencies, the stock price of Capricor Therapeutics (CAPR.US) once plummeted over 60%.

Latest

3 m ago

On Friday, Google's Class A shares closed up 1.45%, with a weekly gain of 0.37%. Amazon closed up 1.24%, with a weekly gain of 0.72%. Tesla closed up 1.17%, with a weekly loss of 0.58%. Nvidia closed up 0.5%, with a weekly gain of 3.5%. Microsoft closed up 0.37%, with a weekly gain of 0.9%. Apple closed down 0.59%, with a weekly loss of 1.12%. Meta closed down 1.34%, with a weekly loss of 0.21%.

3 m ago

Closing report on the seven tech giants in the US stock market

4 m ago

Spot platinum has just broken through the $1400.00 per ounce level, with the latest price at $1400.49 per ounce, up 3.65% on the day; Nymex platinum futures are currently trading at $1472.8 per ounce, up 4.27% on the day.

6 m ago

POLITICO: Canada delays plans to impose retaliatory tariffs on American steel.

8 m ago

Indian investigators have recommended against taking action against Boeing and General Electric following the fatal crash of an Indian Airlines flight. In after-hours trading, Boeing and General Electric shares rose by 0.3% and 1.1% respectively.

See all latest